Literature DB >> 3193214

Therapeutic effectiveness of iodine-131 MIBG metastases of a nonsecreting paraganglioma.

J L Baulieu1, D Guilloteau, F Baulieu, O Le Floch, C Chambon, L Pourcelot, J C Besnard.   

Abstract

This case report describes the treatment of the bone metastases of a nonfunctioning sympathetic paraganglioma, with [131I]MIBG. After primary tumor excision and unsuccessful external radiotherapy, the patient received three therapeutic doses of [131I]MIBG, resulting in a reduction of the number and volume of metastases, and an improvement of the general condition. At 3 yr following [131I]MIBG therapy, the patient remained in remission. [131I]MIBG appears to be an efficient and safe agent for treating malignant sympathetic paraganglioma.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3193214

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  4 in total

1.  Management of metastatic glomus jugulare tumors.

Authors:  D I Bojrab; S A Bhansali; R J Zarbo
Journal:  Skull Base Surg       Date:  1992

2.  Paraganglioma of the pituitary fossa: diagnosis and management.

Authors:  K Salame; G E Ouaknine; J Yossipov; S Rochkind
Journal:  J Neurooncol       Date:  2001-08       Impact factor: 4.130

3.  Radionuclide therapy of malignant pheochromocytoma with 131I-MIBG.

Authors:  Y Nakabeppu; M Nakajo
Journal:  Ann Nucl Med       Date:  1994-11       Impact factor: 2.668

Review 4.  Radionuclide therapy revisited.

Authors:  C A Hoefnagel
Journal:  Eur J Nucl Med       Date:  1991
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.